• AA
  • Share

Meet the 2017 Laureates: Teresa K. Woodruff, PhD

woodruff-teresa

Dr. Teresa Woodruff has been a remarkable leader within the Endocrine Society, at her institution, nationally, and globally.

Among her accomplishments as Endocrine Society president were overseeing changes in brand identity for the Society, a new logo and tagline, the purchase of the new Endocrine Society headquarters, and the hiring of a new CEO. She expanded the advocacy agenda and initiated changes in the Laureate Awards, so they reflect the diverse activities of the members.

At Northwestern, she is the vice chair for research in the Department of Obstetrics and Gynecology and director of the Northwestern University Center for Reproductive Science. Dr. Woodruff is the founder and director of the Oncofertility Consortium, a global program that provides fertility options to young cancer patients. She coined the term “oncofertility” which is now a medical specialty.

Dr. Woodruff is the founder and director of the Women’s Health Research Institute, an organization that provides advocacy on sex-inclusion policies at the local and national level and she is a member of the NIH Office of Research on Women’s Health council. She created the Women’s Health Summer Academy program, including the Oncofertility Saturday Academy, which attracts girls from Chicago to lab and career building programs.

Her accomplishments have been recognized by numerous awards. In 2013, she was ranked 112th in Time Magazine’s Most Influential People in the World list and in 2011 was awarded the Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring, which was presented in the Oval Office. In summary, Dr. Woodruff’s accomplishments have had extraordinary and wide-reaching impact on the Endocrine Society, on endocrine research, on women’s health and science mentoring, and on developing new options for preserving fertility in cancer patients.

You may also like

  • Endocrine Society Response to Immigration Order

    President Donald Trump signed an executive order on Friday, January 27, limiting refugees into the U.S., barring the citizens of seven countries – Iraq, Iran, Syria, Somalia, Sudan, Libya, and Yemen – from entering the U.S. on any visa category, and, consequently, also creating new barriers to the global exchange of scientific information. The order…

  • Rare Endocrine Diseases Highlighted in New Awareness Campaign

    A new global campaign has been launched by Alexion Pharmaceuticals, Inc., to raise awareness of bone disorder hypophosphatasia (HPP), metabolic disease lysosomal acid lipase deficiency (LAL-D), and other rare diseases. Uncommon Strength celebrates the extraordinary resilience and inner strength of individuals impacted by these diseases, according to a company statement. Aside from HPP and LAL-D, the…

Find more in